Across TCGA pan-cancer cohorts, LEPROT mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LEPROT’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LEPROT mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types LEPROT is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD are the cancer types where LEPROT tumor–normal differential expression is most reproducible.